Account-Based Marketing for HCPs: When ABM Thinking Fits Pharma
How account-based marketing applies to pharma: health systems and practices as accounts, coordinated channels, data needs, and account metrics.
The short answer
Account-based marketing for HCPs treats a health system, practice, or group of linked HCPs as one account with a coordinated plan, rather than targeting each HCP independently. It fits pharma when decisions are shared within organizations, such as formularies, protocols, or referral networks. It requires affiliation data, coordination between key account managers and media, account-level content, and measures of progress at the account level.
Account-based marketing comes from B2B software sales, where several people at one company make a purchase decision together. Pharma increasingly looks similar: health systems decide formularies and protocols, and clinicians inside them follow. ABM thinking helps when that is true.
When ABM fits
| Situation | ABM fit |
|---|---|
| Hospital-administered or specialty products | Strong |
| Products needing formulary or protocol inclusion | Strong |
| Rare disease with few treating centers | Strong |
| Retail primary care products with broad coverage | Weaker; individual HCP targeting may do better |
Building an account plan
- Pick accounts. Prioritize by patient volume, access status, and strategic value.
- Map the account. Clinicians, pharmacy and therapeutics committee members, department leaders, practice staff. See HCP mapping.
- Define account goals. Formulary inclusion, protocol update, prescribing breadth across clinicians.
- Assign roles. Key account manager leads; medical, access, and media support.
- Coordinate content. Different roles need different content, consistent in story.
- Track progress by account.
Where media fits
- Awareness across the account's clinicians through NPI-matched programmatic filtered by affiliation.
- Support for account team milestones, such as media timed after a formulary decision. See market access pull-through.
- Professional channels for administrative and pharmacy audiences.
Media teams should not run ABM independently from account teams. That leads to messages that conflict with ongoing negotiations.
Data needs
- Affiliation data linking NPIs to accounts.
- Role data for non-prescribers involved in decisions.
- Engagement data across channels at the account level.
- Prescribing data aggregated by account.
Real-time identity tools can help recognize account engagement online. See real-time identity graphs for ABM.
Measuring account progress
| Stage | Signal |
|---|---|
| Aware | Share of account clinicians reached |
| Engaged | Share engaging with content |
| Access | Formulary or protocol status |
| Adopting | Share of account clinicians prescribing |
| Expanding | Growth in patients treated at the account |
Compare target accounts with similar non-target accounts where possible.
Compliance notes
Account-level interactions involve institutional relationships, which may involve grants, contracts, or transfers of value. These follow company policy, the PhRMA Code, and transparency reporting rules.
Common mistakes
- Calling NPI targeting "ABM" without account coordination.
- Media running account campaigns without the account team.
- Measuring individual HCP clicks instead of account progress.
- Too many accounts to coordinate meaningfully.
Practical takeaway
Choose ten priority accounts and build one-page account plans with goals, roles, and media support. Run them for two quarters and compare progress with ten similar accounts not in the program before scaling.
Frequently asked questions
What is ABM in pharma?
Planning marketing around key accounts, such as health systems or large practices, with coordinated outreach to the clinicians and decision makers in each.
When does ABM make sense for pharma?
When organizations shape prescribing through formularies, protocols, or referral networks, and when a small number of accounts drive a large share of patients.
What data does HCP ABM need?
Affiliation data linking HCPs to accounts, account priority, roles within the account, and engagement data across channels.
Sources
External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.
Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.
New pharma programmatic breakdowns, occasionally
One email when I publish something worth reading. Benchmarks, measurement teardowns, and case studies with the caveats attached. No cadence promises, no reselling your address.
Unsubscribe any time. See the privacy policy.
Working through this decision on a real plan?
I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.